| Cost of Revenue | 1 | 0.03 | 0.03 | 0.11 | 0.03 | |
| Gross Profit | -1 | -0.03 | -0.03 | -0.11 | -0.03 | |
| Selling, General & Admin | 9.99 | 9.78 | 9.9 | 8.88 | 5.68 | |
| Research & Development | 1.18 | 2.94 | 1.15 | 5.98 | 4.05 | |
| Operating Expenses | 11.43 | 13.24 | 11.95 | 15.92 | 9.74 | |
| Operating Income | -12.43 | -13.27 | -11.98 | -16.03 | -9.78 | |
| Interest Expense | -0 | -0 | - | - | - | |
| Interest & Investment Income | 0.28 | 1.35 | 1.05 | 0.03 | - | |
| Currency Exchange Gain (Loss) | -0 | -0.05 | -0.05 | - | - | |
| Other Non Operating Income (Expenses) | -0.5 | 1.12 | 0 | -0 | -0.01 | |
| EBT Excluding Unusual Items | -12.66 | -10.85 | -10.98 | -16.01 | -9.79 | |
| Gain (Loss) on Sale of Investments | - | - | - | 2.06 | - | |
| Gain (Loss) on Sale of Assets | - | - | - | - | -2.67 | |
| Other Unusual Items | - | 3.1 | -0.14 | -2.19 | -1.46 | |
| Pretax Income | -12.66 | -7.75 | -11.12 | -16.14 | -13.91 | |
| Earnings From Continuing Operations | -12.66 | -7.75 | -11.12 | -16.14 | -13.91 | |
| Earnings From Discontinued Operations | - | - | - | - | -9.66 | |
| Net Income | -12.66 | -7.75 | -11.12 | -16.14 | -23.57 | |
| Net Income to Common | -12.66 | -7.75 | -11.12 | -16.14 | -23.57 | |
| Shares Outstanding (Basic) | 59 | 52 | 45 | 33 | 9 | |
| Shares Outstanding (Diluted) | 59 | 52 | 45 | 33 | 9 | |
| Shares Change (YoY) | 12.49% | 15.87% | 37.54% | 271.09% | 348.69% | |
| EPS (Basic) | -0.22 | -0.15 | -0.25 | -0.49 | -2.68 | |
| EPS (Diluted) | -0.22 | -0.15 | -0.25 | -0.49 | -2.68 | |
| Free Cash Flow | -11.96 | -69.73 | -65.97 | -22.93 | -15.26 | |
| Free Cash Flow Per Share | -0.20 | -1.34 | -1.47 | -0.70 | -1.74 | |
| EBITDA | -12.18 | -13.05 | -11.84 | -16.01 | -9.56 | |
| D&A For EBITDA | 0.25 | 0.22 | 0.15 | 0.02 | 0.22 | |
| EBIT | -12.43 | -13.27 | -11.98 | -16.03 | -9.78 | |